CVS, Upbeat Q4

Top Analysts Upgrade CVS Health Stock (CVS) after Upbeat Q4 Results
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a recent >10% stock rally. See more.
CVS Health (NYSE:CVS) Upgraded at Leerink Partnrs
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.
CVS Health Is About to Report Q4 Earnings Tomorrow. Here’s What to Expect
Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market opens on
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.
CVS Health: Earnings Beat Ignites Stock Rally
Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline,
Leerink Partners Upgrades CVS Health (CVS)
Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform. Analyst Price Forecast Suggests 3.67% Upside As of January 28,
CVS Health 2024 Profits Eclipse $4.6 Billion Despite Rising Costs
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
CVS Health stock soars on surprise boost from health insurance unit
CVS Health posted stronger-than-expected fourth quarter earnings Wednesday, including a narrowing of its key benefit-expense ...
CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25
CVS Health topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. "We have continued to ...
CVS Health's Turnaround Efforts in Focus Amid Record-High Medical Costs
It reported a medical loss ratio - a percentage of premiums spent on medical care - at a record high of 95.2% in October, as ...
Morningstar1d
CVS Health Corp
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus
Wall Street snapped a two-week losing streak as headlines about President Donald Trump's remarks on tariff policy, economic data on inflation and corporate earnings took center stage. The S&P ...
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as its pace of medical cost increases ...